“Non-Alcoholic Fatty Liver Disease (NAFLD) Drug Discovery Through the Application of Quantitative Systems Pharmacology and Microphysiology Systems”
D. Lansing Taylor, PhD presenting at the 3D Tissue Models meeting, September 4-6, 2019, Boston, MA.
D. Lansing Taylor, PhD presenting at the 3D Tissue Models meeting, September 4-6, 2019, Boston, MA.
“Non-Alcoholic Fatty Liver Disease (NAFLD) Drug Discovery Through the Application of Quantitative Systems Pharmacology and Microphysiology Systems”